Developing near-infrared responsive liquid crystal elastomers for an adjustable pulmonary artery band
开发用于可调节肺动脉带的近红外响应液晶弹性体
基本信息
- 批准号:10537663
- 负责人:
- 金额:$ 4.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-17 至 2026-08-16
- 项目状态:未结题
- 来源:
- 关键词:3D PrintAcuteAddressAdoptedAffectAnimalsArteriesBiocompatible MaterialsBiological TestingBloodBlood CirculationBlood flowBody WeightCaliberCardiacCathetersCell Culture TechniquesCellsCessation of lifeChildChronicClinicalColoradoCommunicationCongenital Heart DefectsCritical Congenital Heart DefectsDefectDevelopmentDevicesEchocardiographyElastomersElementsEngineeringEvolutionExhibitsFellowshipFiber OpticsFutureGoalsGoldGoretexGrowthHealth Care CostsImmune responseImplantIn VitroInfantInternationalLasersLifeLife ExpectancyLightLungMechanicsMediatingMedical DeviceMedical Device DesignsMedical TechnologyMentorshipMorbidity - disease rateMusNear-Infrared SpectroscopyNewborn InfantOperative Surgical ProceduresOpticsPatient-Focused OutcomesPatientsPenetrationPerformancePersonsPhysiologicalPolymer ChemistryPolymersPrevalenceProceduresPublishingPulmonary HypertensionPulmonary artery structureQuality of lifeRegulationRepeat SurgeryReportingResearch ActivityResearch Project GrantsResearch ProposalsResearch TrainingRiskScientistShapesSkinSourceStimulusSumSurfaceSurface PropertiesSurgeonTechnical ExpertiseTechniquesTestingTissuesTrainingTranslatingTranslationsTransmission Electron MicroscopyUnited StatesUniversitiesWorkbasebiomaterial compatibilitycancer therapycareercareer developmentconstrictioncostcrosslinkcytotoxicitycytotoxicity testdesignglobal healthhemodynamicsimplantationimprovedimproved outcomein vivoirradiationlight scatteringliquid crystalmedical implantminimally invasivemortalitynanocompositenanorodnoveloutreachpalliatepalliationpalliativepatient prognosisperformance testspreclinical studypressureresponsescaffoldskillssubcutaneoussurgery materialtool
项目摘要
Project Summary
Approximately 1 in 100 children born in the United State have a congenital heart defect (CHD). Nearly a
quarter of these children present with “critical” CHDs, requiring surgical intervention within the first year of life.
For patients in which a CHD is the source of pulmonary hypertension (e.g., the unrestricted flow of blood to the
lungs), a palliative pulmonary artery band (PAB) can be applied to regulate blood flow. Conventional PABs are
fixed and thus commit children to repeated surgeries if adjustments are needed due to altered hemodynamics
and/or to accommodate growth. As a result, the affected children suffer from high morbidity and mortality. This
proposal addresses this clinical need by developing and optimizing novel stimuli-responsive materials for
integration with PABs to permit adjustability.
Light is an ideal stimulus to introduce minimally invasive reconfigurability to the PAB. The objective of
this research activity is to integrate photoresponsive materials with PABs to enable the diameter of the PAB to
be reconfigured via light delivered by an endovascular fiber-optic catheter through the artery wall. Aim 1 is
focused on material development and integration into novel PAB designs that leverage the stimuli-responsive
material. Aim 2 will assess the cellular and host responses to the stimuli-responsive material and develop
strategies to engineer these responses if necessary. Long-term, the evolution of stimuli-responsive materials will
lead to a wide variety of growth-accommodating and shape-changing medical devices that will improve patient
outcomes and quality of life.
This collaborative research project will be undertaken at the University of Colorado Boulder with
mentorship and support from Dr. Timothy White and Dr. Kristi Anseth. The training plan includes development
of technical skills (e.g. polymer chemistry, medical device design, and biological testing of biomaterials) and
professional skills (e.g. communication skills, career development, and scientific outreach). In sum, this
application will provide the applicant with invaluable training for his future career as a surgeon-scientist focused
on translating novel biomaterials into impactful medical devices and technologies.
项目摘要
在美国出生的每100名儿童中就有1名患有先天性心脏病(CHD)。近一
这些儿童中有四分之一患有“严重”CHD,需要在生命的第一年内进行手术干预。
对于CHD是肺动脉高压来源的患者(例如,血液不受限制地流向
肺),可以应用姑息性肺动脉带(PAB)来调节血流。传统的PAB是
如果由于血流动力学改变而需要调整,
和/或适应增长。因此,受影响儿童的发病率和死亡率很高。这
一项提案通过开发和优化新型刺激响应材料来满足这一临床需求,
与PAB集成以允许可调节性。
光是将微创重构引入PAB的理想刺激。的目标
这项研究活动是将光敏材料与PAB结合起来,使PAB的直径能够
通过由血管内光纤导管通过动脉壁递送的光来重新配置。目标1是
专注于材料开发和集成到新型PAB设计中,
材料目的2将评估细胞和宿主对刺激响应材料的反应,并开发
在必要时设计这些反应的策略。从长远来看,刺激响应材料的演变将
导致了各种各样适应生长和改变形状的医疗装置,
结果和生活质量。
这项合作研究项目将在科罗拉多博尔德大学进行,
Timothy白色博士和Kristi Anseth博士的指导和支持。培训计划包括发展
技术技能(例如,聚合物化学、医疗器械设计和生物材料的生物学试验),以及
专业技能(如沟通技能、职业发展和科学推广)。总之,这
申请将为申请人提供宝贵的培训,为他未来的职业生涯作为一个外科医生,科学家为重点
将新型生物材料转化为有影响力的医疗设备和技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nathaniel Phillip Skillin其他文献
Nathaniel Phillip Skillin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nathaniel Phillip Skillin', 18)}}的其他基金
Developing near-infrared responsive liquid crystal elastomers for an adjustable pulmonary artery band
开发用于可调节肺动脉带的近红外响应液晶弹性体
- 批准号:
10778190 - 财政年份:2022
- 资助金额:
$ 4.16万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 4.16万 - 项目类别:
Operating Grants














{{item.name}}会员




